Corteva, Inc. $CTVA Shares Sold by Natixis Advisors LLC

Natixis Advisors LLC lessened its stake in shares of Corteva, Inc. (NYSE:CTVA) by 1.4% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 636,627 shares of the company’s stock after selling 9,101 shares during the quarter. Natixis Advisors LLC owned about 0.09% of Corteva worth $43,055,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of CTVA. Activest Wealth Management boosted its position in Corteva by 118.3% during the third quarter. Activest Wealth Management now owns 369 shares of the company’s stock worth $25,000 after acquiring an additional 200 shares during the last quarter. True Wealth Design LLC lifted its stake in shares of Corteva by 209.5% during the 3rd quarter. True Wealth Design LLC now owns 390 shares of the company’s stock worth $26,000 after purchasing an additional 264 shares during the period. Total Investment Management Inc. acquired a new stake in shares of Corteva during the second quarter worth $27,000. Twin Peaks Wealth Advisors LLC acquired a new stake in shares of Corteva during the second quarter worth $29,000. Finally, Redmont Wealth Advisors LLC purchased a new stake in shares of Corteva in the third quarter valued at $29,000. Institutional investors and hedge funds own 81.54% of the company’s stock.

Analysts Set New Price Targets

CTVA has been the topic of several recent analyst reports. Oppenheimer set a $86.00 target price on Corteva in a research report on Thursday, February 5th. BNP Paribas Exane upped their price objective on shares of Corteva from $72.00 to $74.00 in a research note on Monday. JPMorgan Chase & Co. lowered shares of Corteva from an “overweight” rating to a “neutral” rating and increased their price objective for the stock from $75.00 to $77.00 in a report on Thursday, February 5th. Wall Street Zen cut shares of Corteva from a “buy” rating to a “hold” rating in a research report on Saturday, February 7th. Finally, UBS Group downgraded shares of Corteva from a “buy” rating to a “hold” rating in a report on Monday, February 9th. One analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and eight have given a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $82.90.

Insider Activity at Corteva

In related news, insider Brian Titus sold 8,311 shares of the business’s stock in a transaction that occurred on Friday, February 20th. The stock was sold at an average price of $76.55, for a total transaction of $636,207.05. Following the transaction, the insider directly owned 8,090 shares of the company’s stock, valued at approximately $619,289.50. The trade was a 50.67% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Insiders own 0.15% of the company’s stock.

Corteva Stock Performance

Shares of CTVA stock opened at $78.36 on Tuesday. The company has a current ratio of 1.43, a quick ratio of 0.96 and a debt-to-equity ratio of 0.07. The company has a market cap of $52.70 billion, a PE ratio of 49.59, a P/E/G ratio of 2.63 and a beta of 0.72. The company’s fifty day simple moving average is $73.22 and its 200-day simple moving average is $69.04. Corteva, Inc. has a 52 week low of $53.40 and a 52 week high of $80.90.

Corteva (NYSE:CTVA) last announced its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.22. Corteva had a net margin of 6.29% and a return on equity of 9.06%. The firm had revenue of $3.91 billion during the quarter, compared to analysts’ expectations of $4.23 billion. During the same period in the prior year, the company earned $0.32 EPS. The firm’s revenue was down 1.7% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, equities research analysts anticipate that Corteva, Inc. will post 2.96 EPS for the current year.

Corteva Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, March 16th. Stockholders of record on Monday, March 2nd will be paid a $0.18 dividend. The ex-dividend date is Monday, March 2nd. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. Corteva’s dividend payout ratio (DPR) is 45.57%.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.